HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.

Abstract
Background: Maryland expanded its "Statewide Naloxone Standing Order" (NSO) in 2017 to eliminate training and prescription requirements for obtaining naloxone, improve naloxone access, help reverse opioid overdose, and reduce overdose fatality rates.Objectives: To assess the change in the trends of fatal opioid overdose rates following the expansion of the Naloxone Standing Order (eNSO) and its association with the social determinants of health (SDoH).Methods: Data on overdose deaths and SDoH from 2015-2019 was collected and analyzed using interrupted time series and multivariate Poisson regression models to study the change in trends and the associations.Results: There was a significant decrease in the rate of fatal overdoses after the intervention: prescription opioid estimate number of deaths declined by .25 per 100,000 (p = .02), heroin estimate number of deaths declined by 1.83 per 100,000 (p < .001), fentanyl estimate number of deaths declined by 2.54 per 100,000 (p < .001). After controlling for eNOS implementation in Maryland, state-level estimates with high proportions of female residents and those with bachelor's degree or higher were associated with reduction in overdose, while state-level estimates with high proportions of African Americans and higher employment rates were associated with an increase in overdose.Conclusions: Our analysis shows that the expanded naloxone standing order is associated with reducing opioid-related overdose death rates. Even though we observed a significant reduction in overdose death rate in fentanyl-related deaths, the rate of deaths post-eNSO was still increasing, suggesting the need for additional measures to impact the rates of fentanyl.
AuthorsMichelle Taylor, Apoorva Pradhan, Yoscar M Ogando, Fadia Shaya
JournalThe American journal of drug and alcohol abuse (Am J Drug Alcohol Abuse) Vol. 48 Issue 3 Pg. 338-346 (05 04 2022) ISSN: 1097-9891 [Electronic] England
PMID35467459 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Opioid
  • Narcotic Antagonists
  • Naloxone
  • Fentanyl
Topics
  • Analgesics, Opioid (therapeutic use)
  • Drug Overdose (drug therapy)
  • Female
  • Fentanyl
  • Humans
  • Naloxone (therapeutic use)
  • Narcotic Antagonists (therapeutic use)
  • Opiate Overdose (epidemiology)
  • Opioid-Related Disorders (drug therapy)
  • Standing Orders

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: